Elanco Animal Health (ELAN) Cash from Investing Activities (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Cash from Investing Activities data on file, last reported at -$60.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 3.45% year-over-year to -$60.0 million; the trailing twelve-month figure through Mar 2026 stood at -$281.0 million (down 126.43% YoY), and the FY2025 full-year result was -$279.0 million, down 124.09% from the prior year.
• Cash from Investing Activities climbed to -$60.0 million in Q1 2026, from -$64.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $1.2 billion in Q3 2024 to a low of -$101.0 million in Q3 2025.
• A 5-year average of $27.7 million and a median of -$43.0 million in 2023 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities plunged 390.0% in 2022 and soared 3555.56% in 2024, its largest moves.
• Tracing ELAN's Cash from Investing Activities over 5 years: stood at -$76.0 million in 2022, then soared by 53.95% to -$35.0 million in 2023, then tumbled by 157.14% to -$90.0 million in 2024, then increased by 28.89% to -$64.0 million in 2025, then increased by 6.25% to -$60.0 million in 2026.
• Business Quant data shows ELAN's Cash from Investing Activities at -$60.0 million in Q1 2026, -$64.0 million in Q4 2025, and -$101.0 million in Q3 2025.